Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IBSE: ANGEN)
Health Care · Biotechnology · TR
TL7.12
-13.59% today · -38.1% 1Y
Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IBSE: ANGEN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $31.63M.
Over the last twelve months the share price has lost 38.1%, trading between 6.66 and 16.00.
Tweenvest scores Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. across four factors: quality 64/100, value 50/100, growth 67/100. Its strongest factor is growth.
ANGEN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $31.63M
- Revenue (TTM)
- $16.02M
- P/E
- —
- EPS
- -1.17
- Dividend yield
- —
- Beta (5Y)
- 0.06
- 52-week high
- TL16.00
- 52-week low
- TL6.66
- Avg volume (3M)
- —
- Shares outstanding
- 220.00M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Kringle Pharma, Inc.TSE: 4884 | $32.60M | ¥614.00 | -4.81% |
| Quince Therapeutics, Inc.NasdaqGS: QNCX | $32.58M | $32.03 | +0.95% |
| GeneBioTech Co. ,LtdKOSDAQ: A086060 | $32.23M | ₩4,990.00 | -1.58% |
| Celularity Inc.NasdaqCM: CELU | $31.73M | $0.98 | -6.89% |
| GeneOne Life Science, Inc.KOSE: A011000 | $31.40M | ₩— | — |
| Medicure Inc.TSXV: MPH | $31.36M | CA$4.25 | +42.62% |
| Organoidsciences Ltd.KOSDAQ: A476040 | $31.32M | ₩6,340.00 | -7.45% |
| Oncocross Co., Ltd.KOSDAQ: A382150 | $31.31M | ₩3,200.00 | -12.45% |
Figures last refreshed Oct 18, 2026.